Filing Flows › Cardlytics (CDLX) › Q2 2026 › vs Q1 2026
Cardlytics (CDLX) Q2 2026 vs Q1 2026 (quarter over quarter)
Cardlytics's revenue rose $2.6M (+7%) from $34.3M in Q1 2026 to $36.9M in Q2 2026. The biggest changes: Served based pricing +$1.8M (+17%); Engagement based pricing +$901K (+4%); Other Revenue(1) −$95K (-7%).
Cardlytics, Q2 2026: revenue $36.9M (-36% year over year), operating margin -14.8%, net loss $14.9M, operating cash flow −$8.6M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Engagement based pricing | $23.9M | $23.0M | $901K | +4% |
| Served based pricing | $11.8M | $10.1M | $1.8M | +17% |
| Other Revenue(1) | $1.2M | $1.3M | −$95K | -7% |
| Revenue | $36.9M | $34.3M | $2.6M | +7% |
| Net loss | $14.9M | $4.5M | $10.4M | +232% |
| Costs & expenses | $51.8M | $42.6M | $9.2M | +22% |
| Operating costs | $42.3M | $42.6M | −$270K | -0.6% |
| Interest & other, net | $9.4M | −$3.8M | $13.2M | — |
| Research & development | $5.5M | $6.4M | −$890K | -14% |
| Sales & marketing | $6.6M | $6.8M | −$156K | -2% |
| General & admin | $7.9M | $8.3M | −$426K | -5% |
| Other operating costs | $22.3M | $21.1M | $1.2M | +6% |
| Operating cash sources | $15.0M | $14.9M | $125K | +0.8% |
| Depreciation & amortization | $4.1M | $4.4M | −$357K | -8% |
| Share-based compensation | $2.4M | $4.8M | −$2.5M | -51% |
| Cash used in operations | $8.6M | $5.6M | $3.0M | +52% |
| Net loss absorbed | $14.9M | $4.5M | $10.4M | +232% |
| Working capital & other | $137K | $10.4M | −$10.3M | -99% |
Questions
How much did Cardlytics's revenue grow quarter over quarter in Q2 2026?
Cardlytics's revenue rose $2.6M (+7%) from $34.3M in Q1 2026 to $36.9M in Q2 2026.
What drove Cardlytics's revenue change in Q2 2026?
Served based pricing +$1.8M (+17%); Engagement based pricing +$901K (+4%); Other Revenue(1) −$95K (-7%).